The role of the DST was to help Performing Provider Systems with technical assistance in developing their DSRIP Project Plan
People who are recovering from tendon, ligament, or muscle injuries, with persistent gut disorders (IBD, ulcers, leaky gut), inflammation or tissue damage from NSAIDs, wanting speedier surgery or injury recovery, managing brain-gut dysfunction or systemic inflammation.
The GLP-1 and GIP receptors encourage the release of insulin in the body from the pancreas
Key quantitative findings included dose-dependent increases in CXXC5 expression following PGD2 treatment, corresponding decreases in beta-catenin and PCNA (a proliferation marker), restoration of Wnt signaling and cellular proliferation with PTD-DBM treatment, and complete resistance to PGD2-induced hair loss in CXXC5 knockout mice